Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases

Details for Australian Patent Application No. 2010250923 (hide)

Owner AstraZeneca AB Dainippon Sumitomo Pharma Co., Ltd

Inventors Bennett, Nicholas James; McInally, Thomas; Thom, Stephen

Agent Davies Collison Cave

Pub. Number AU-A-2010250923

PCT Pub. Number WO2010/133885

Priority 61/180,238 21.05.09 US

Filing date 20 May 2010

Wipo publication date 25 November 2010

International Classifications

C07D 239/49 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/133885 Priority application(s): WO2010/133885

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010250924-Gypsum building boards

2010250921-Rock bolt with separate mixing-and discharge head